Geographic Information Systems: Opportunities & Challenges in Cancer Outcomes Research
Paris, France 2020
Understanding Real World Cancer Care and Outcomes: Opportunities for International Collaboration
Beijing, China 2019
Creating and Implementing Clinical Pathways: Where is the Patient Voice?
San Diego, United States 2019
Assessing the Use and Effectiveness of Precision Oncology with Real World Data
Chicago, United States 2019
Innovation & Cancer Care (Panel Discussion)
New York, United States 2019
Contemporary Tumor Registries: What’s Bigger than Big Data?
Hartford, United States 2019
Trends in checkpoint inhibitor therapy for advanced urothelial cell carcinoma (aUC) at the end of life: Insights from real-world practice. Parikh RB, Galsky M, Gyawali B, Riaz F, Kaufmann T, Cohen A, Adamson B, Gross CP, Meropol N, Mamtani R.
Chicago, United States 2019
Contemporary changes in localized and metastatic prostate cancer incidence by geographic area following decreased PSA screening.
Chicago, United States 2019
Chromosome 1 abnormalities and clinical outcomes in multiple myeloma in the era of novel agents. Giri S, Huntington SF, Wang R, Zeidan AM, Podoltsev N, Gore S, Ma X, Gross CP, Davidoff A, Neparidze N.
Chicago, United States 2019
Affordable Care Act (ACA) Medicaid expansion impact of racial disparities in time to cancer treatment. Adamson B, Cohen A, Estevez M, Magee K, Williams E, Gross CP, Meropol N, Davidoff A.
Chicago, United States 2019
Real-world practice patterns and impact of PD-L1 expression testing in patients with advanced non-small cell lung cancer. Leapman M, Presley C, Zhu W, Soulos P, Adelson K, Boffa D, Gross CP.
Chicago, United States 2019
Impact of an oncology urgent care clinic on emergency department rates. Sedghi T, Canavan M, Gross CP, Davidoff A, Gould Rothberg E, Strait M, Sinanis N, Adelson K.
Chicago, United States 2019
Abandonment trajectories of conventionally fractionated adjuvant radiotherapy in breast cancer care. Xu, X, Gross, CP.
Chicago, United States 2019
Transforming Cancer Screening and Care in the Modern Era: Time to Pump the Brakes?
New York, United States 2018
The Academic Perspective on Real World Evidence
Washington, United States 2018
Is Sharing Clinical Research Data Ready for Prime Time? Lesson’s Learned from the YODA Project
Chicago, United States 2018
Cancer Screening and Follow-up Care: Too little, Too Much, but Never Too Late
Chicago, United States 2018
Prioritization of patient reported outcomes by women with metastatic breast cancer. Mougalian SS, Aminawung JA, Presley C, Canavan ME, Holland ML, Hu X, Gross CP.
San Antonio, United States 2018
Association between Oncologist Ownership of Imaging Facilities and Utilization: An Analysis of Positron-Emission Tomography (PET) Use in Lymphoma Settings with Variable PET Utility. Huntington SF, Zhu W, Hoag J, Wang R, Zeidan AM, Giri S, Podoltsev NA, Gore SD, Ma X, Gross CP, Davidoff AJ.
San Diego, United States 2018
Persistent use of extended fractionation palliative radiotherapy for Medicare beneficiaries with metastatic breast cancer: 2011-2014. Yu J, Pollack C, Herrin J, Zhu W, Soulos P, Xu X, Gross C.
San Antonio, United States 2018
State breast density inform mandate laws, use of adjunctive tests and cancer detection following screening mammography. Busch S, Hoag J, Aminawung J, Xu X, Richman I, Soulos P, Kyanko K, Gross C.
Chicago, United States 2018
Early Adoption of Digital Breast Tomosynthesis into Clinical Practice: A National Study. Richman I, Hoag J, Forman H, Busch S, Gross C.
Denver, United States 2018
Adoption of New Cancer Screening Modalities in a Privately Insured Population
Chicago, United States 2017
Irrational Exuberance and the Evolution of Cancer Care in the 21st Century
Baltimore, United States 2017
Understanding Conflicts of Interest – Evolution of a Research Agenda. Or: How I Learned to Stop Worrying and Love Big Pharma
Baltimore, United States 2017
Could Social Contagion Help Us Improve Value in Cancer Care & Research?
Boston, United States 2017
Early Insights from an Academic-Industry Collaboration Unlocking Real-World Clinical Data
Palo Alto, United States 2017
Contagious Knowledge: Social Networks, Open Science, & the Effort to Improve Cancer Outcomes
New York, United States 2017
Stereotactic body radiation therapy for oligometastatic disease: a multi-institutional retrospective survival analysis. Bui D, Magnuson W, Lester-Coll N, Qian J, Ross R, Soulos P, Shafman T, Dosoretz A, Evans S, Yu J, Gross C, Decker R.
San Diego, United States 2017
Racial disparities in the use of programmed death 1 checkpoint inhibitors.
Chicago, United States 2017
Disparities in Next Generation Sequencing in a Population-Based Community Cohort of Patients with Advanced Non-Small Cell Lung Cancer. Presley CJ, Soulos PR, Chiang AC, Longtine JA, Adelson KB, Herbst RS, Nussbaum NC, Sorg R, Abernethy AP, Agarwala V, Gross CP.
Chicago, United States 2017
Physician volume and discontinuation of rituximab during lymphoma treatment. Huntington SF, Long JB, Hoag JR, Wang R, Zeidan AM, Gore S, Ma X, Gross CP, Davidoff AJ.
Chicago, United States 2017
Socioeconomic disparities in needle biopsy prior to breast cancer surgery across physician referral networks. Killelea BK, Herrin J, Soulos PR, Pollack C, Forman H, Yu J, Xu X, Tannenbaum S, Wang S, Oladele C, and Gross CP.
San Antonio, United States 2016
Modern Radiotherapy for Left–Sided Breast Cancer: An Analysis of Mean Heart Dose within Diverse Practice Settings. Hong J, Gross C, Shafman T, Hu X, Yu J, Ross R, Dosoretz A, Park H, Soulos P, Evans S, Finkelstein S.
Boston, United States 2016
Pt-reported QOL aft SBRT vs. modhypofractionation for clin loc prostate ca. Johnson SB, Soulos PR, Shafman TD, Mantz CA, Dosoretz A, Ross R, Finkelstein SE, Collins SP, Suy S, Brower JV, Ritter MA, King CR, Kupelian PA, Horwitz EM, Pollack A, Abramowitz MC, Hallman MA, Faria S, Gross CP, and Yu JB.
Boston, United States 2016
A biologic effect dose ≥105Gy assoc w improved overall survival stage I non-sm cell lung ca patients treated with stereotactic body radiation therapy. Stahl JM, Ross R, Harder EM, Mancini BR, Soulos PR, Dosoretz AP, Finkelstein SE, Shafman TD, Husain ZA, Evans SB, Yu JB, Gross CP, and Decker RH.
Boston, United States 2016
Examining Trends in the CMS Medicare Provider Utilization and Payment Database for Radiation Oncologists. Jairam V, Gross C, Yu J.
Boston, United States 2016
Bone density screening in postmenopausal females with early stage breast cancer on aromatase inhibitors. Stratton J, Hu X, Soulos PR, Davidoff AJ, Pusztai L, Gross CP, Mougalian S.
Chicago, United States 2016
Associations of pre- and post-cancer depression with end-of-life cancer care intensity. Doan K, Levy BR, Gross CP, Wang S.
Chicago, United States 2016
The Impact of Social Contagion on Physician Adoption of Breast Cancer Imaging. Pollack CE, Soulos PR, Herrin J, Xu X, Christakis N, Forman HP, Yu J, Killelea BK, Wang S, Gross CP.
Chicago, United States 2016
Association of Length of Hospice Enrollment with Regional Variation in End-of-Life Healthcare Expenditures. Wang S, Huang S, Hsu SH, Gross CP.
Chicago, United States 2016
Identifying Social Networks for Provider Care: Assessing Stability. Herrin J, Soulos PR, Pollack CE, Gross CP.
Boston, United States 2016
Open Science, Transparency, & Data Sharing
Washington, United States 2015
Yale Open Data Access Project: Overview and Lessons Learned
London, United Kingdom 2015
The Quest for Value in Cancer Care and Research in the US and the UK
London, United Kingdom 2015
Changes in Medicare Supplemental Medical and Drug Coverage Associated with a Health Shock: The Case of Cancer. Davidoff AJ, Gross CP, Soulos PR, Hall J.
Minneapolis, United States 2015
Association Between Supplemental Coverage and Stage at Cancer Diagnosis: New Evidence from SEER-Medicare. Davidoff AJ, Gross CP, Soulos PR, Hall J.
Minneapolis, United States 2015
Trends and regional variation of end-of-life cancer care in the Medicare program. Wang S, Hall J, Pollack C, Adelson K, Bradley E, Long J, Gross CP.
Chicago, United States 2015
Outcomes of adjuvant ACT vs. TC chemotherapy in older women with breast cancer. Mougalian SS, Long JB, Hall J, Adelson K, Abu-Khalaf M, Pusztai L, Gross CP.
Chicago, United States 2015
“The burden upon me”: The complexity of healthcare utilization among Medicare patients undergoing curative treatment for early-stage non-small cell lung cancer. Presley CJ, Soulos PR, Yu JB, Gross CP.
Chicago, United States 2015
Disease-specific costs of care and survival among Medicare-enrolled patients with myelodysplastic syndromes. Zeidan AM, Wang R, Davidoff AJ, Gore SD, Gross CP, Ma X.
Washington, United States 2015
Second myeloid malignancy in prostate cancer patients after radiotherapy, a population-based study. Wang R, Zeidan A, Soulos PR, Yu JB, Davidoff AJ, Gore SD, Gross CP, Ma X.
Washington, United States 2015
County-Level Physician Supply and Utilization of Mohs Micrographic Surgery among Medicare Beneficiaries. Maroongroge S, Ross JS, Gross C, Lott JP.
San Francisco, United States 2015
Improving Cancer Outcomes: Can Researchers be Change Agents?
Chicago, United States 2014
Does Adoption of New Technology Improve Cancer Outcomes?
London, United Kingdom 2014
Improving Cancer Outcomes with Big Data
London, United Kingdom 2014
Improving Cancer Outcomes: Is Research the Problem or the Solution
London, United Kingdom 2014
Improving Cancer Outcomes: Is Research the Problem or the Solution
London, United Kingdom 2014
Improving Cancer Outcomes: Is Research the Solution or the Problem
San Diego, United States 2014
The adoption of hypofractionated whole breast irradiation for early-stage breast cancer: A national cancer data base analysis. Wang E, Mougalian SS, Soulos PR, Rutter CE, Evans SB, Haffty BG, Gross CP, Yu JB.
San Antonio, United States 2014
Surveillance Practice Patterns after Curative Intent Therapy for Stage I Non-Small-Cell Lung Cancer in the Medicare Population. Erb CT, Soulos PR, Tanoue L, Gross CP.
Austin, United States 2014
Impact of three decades of screening on racial disparities in cervical cancer incidence. Yang D, Soulos PR, Davis B, Gross CP, Yu JB.
San Francisco, United States 2014
Comparative effectiveness of stereotactic body radiotherapy vs. surgery for stage I non-small cell lung cancer. Yu JB, Soulos PR, Cramer LD, Decker RH, Kim AW, Gross CP.
San Francisco, United States 2014
Cardiologist Consultation and Associated Outcomes for Older Women with Heart Failure after Breast Cancer Therapy. Chen J, Long JB, Chen C, Wang SY, Steingart RM, Gross CP.
Baltimore, United States 2014
Cardiovascular Events, Early Discontinuation of Trastuzumab, and Their Impact on Survival. Chen J, Wang SY, Long JB, Hurria A, Owusu C, Steingart RM, Gross CP.
Baltimore, United States 2014
Development and validation of a prognostic index for fracture risk in older men undergoing prostate cancer treatment. Graham-Steed TR, Soulos PR, Dearing N, Concato J, Tinetti ME, Gross CP.
Chicago, United States 2014
Estimating the impact of three decades of screening on racial disparities in cervical cancer incidence. Yang D, Soulos PR, Davis B, Gross CP, Yu JB.
Chicago, United States 2014
Diffusion of stereotactic body radiotherapy (SBRT) for early stage non-small cell lung cancer in the Medicare population, 2007-2009. Yu JB, Soulos PR, Cramer LD, Decker, RH, Kim AW, Gross CP.
Chicago, United States 2014
Surgical Delay for Melanoma among Medicare Beneficiaries. Lott J, Soulos PR, Aminawung J, Gross CP.
Denver, United States 2014
Stereotactic body radiosurgery versus intensity modulated radiotherapy for prostate cancer: Comparison of toxicity. Yu JB, Cramer LD, Herrin J, Soulos PR, Potosky AL, Gross CP.
San Francisco, United States 2014
Embracing Complexity: Integrating Multimorbidity into the Cancer Disparities Research Framework
Atlanta, United States 2013
Integrating value into the care of older persons with cancer: Rational decisions or rationing care?
Farmington, United States 2013
Association of partial nephrectomy and presence of robotic surgery for kidney cancer in the United States. Kardos SV, Shuch B, Schulam PG, Gross CP, Shah ND, Trinh Q, Smaldone MC, Sun M, Weight CJ, Sammon J, Han LC, Kim SP.
Bethesda, United States 2013
A Clinical Risk Score Predicting Heart Failure and Cardiomyopathy after Adjuvant Trastuzumab Therapy for Breast Cancer. Ezaz G, Long JB, Gross CP, Chen J. A
Dallas, United States 2013
Quality of breast cancer care in the US territories: Insights from the Medicare program. Layne TM, Aminawung J, Soulos PR, Nunez-Smith M, Nunez MA, Jones BA, Wang K, Gross CP.
Boston, United States 2013
Dissemination of New Technologies and Temporal Trends in Curative Therapy for Prostate Cancer Patients with Low Likelihood of Clinical Benefit. Raldow A, Presley CJ, Yu JB, Cramer LD, Soulos PR, Long JB, Makarov DV, Gross CP.
Atlanta, United States 2013
Changes in Early and Late Stage Colorectal Cancer Incidence During the Era of Screening: 1976-2009.
Atlanta, United States 2013
Stereotactic Radiosurgery versus Intensity Modulated Radiotherapy for Prostate Cancer: Comparison of Early Toxicity. Yu JB, Cramer LD, Herrin J, Soulos PR, Potosky AL, Gross CP.
Atlanta, United States 2013
For-profit hospital ownership status and use of brachytherapy after breast-conserving surgery. Sen S, Soulos PR, Herrin J, Roberts KB, Yu JB, Lesnikoski B, Ross JS, Krumholz HM, Gross CP.
Chicago, United States 2013
Changes in early- and late-stage colorectal cancer incidence during the era of screening: 1976-2009. Yang DX, Gross CP, Yu JB.
Chicago, United States 2013
The Impact of Age and Comorbidity on Cancer Screening
New York, United States 2012
Introducing National Private Insurance Claims Data for Research
Washington, United States 2012
Early Termination of Adjuvant Trastuzumab Associated with Cardiovascular Events in Older Women with Breast Cancer. Chen J, Long JB, Hurria A, Owusu C, Steingart RM, Gross CP.
Los Angeles, United States 2012
Comparison of the Level of Evidence Supporting Practice Guidelines in Cancer Care Between Therapeutic Modalities. Buscariollo D, Lloyd S, Gross CP, Makarov DV, Yu YB.
Boston, United States 2012
The Funding of Phase 3 Clinical Trials Examining Radiation Compared with That of Other Modalities. Lloyd S, Buscariollo D, Gross CP, Makarov DV, Yu YB.
Boston, United States 2012
An Assessment of the Collective Efforts of Clinical Trials to Provide Evidence-Based Practice Guidelines in Cancer Care. Lloyd S, Buscariollo D, Gross CP, Makarov DV, Yu YB.
Boston, United States 2012
Temporal Trends in Radiation Modalities Among Older Women with Favorable Risk Breast Cancer. Roberts KB, Soulos PR, Yu JB, Evans SB, Long JB, Gross CP.
Boston, United States 2012
Understanding Costs and Value of Newer Radiation Modalities among Older Women with Breast Cancer. Sen S, Soulos PR, Frick KD, Long JB, Roberts KB, Yu JB, Evans SB Chagpar AB, Gross CP.
Boston, United States 2012
Proton Radiotherapy For Prostate Cancer In The Medicare Population: Patterns Of Care And Comparison Of Early Toxicity With Intensity Modulated Radiotherapy.
Boston, United States 2012
Factors associated with life expectancy among older adults receiving palliative chemotherapy. Hurria A, Hardt M, Tew WP, Mohile SG, Owusu C, Gross CP, Gajra A, Lichtman SM, Katheria V, Ramani R, Zavala L, Klepin HD.
Chicago, United States 2012
The evolution of breast cancer screening in the Medicare population: Clinical and economic implications. Killelea BK, Long JB, Ma X, Wang R, Chagpar AB, Ross J, Gross CP.
Chicago, United States 2012
An Assessment of the Collective Efforts of Clinical Trials to Provide Evidence-Based Practice Guidelines in Cancer Care. Lloyd S, Buscariollo DL, Gross CP, Makarov DV, Yu JB.
Chicago, United States 2012
Anemia and Functional Disability in Older Adults. Owusu C, Tew WP, Hardt M, Mohile SG, Klepin HD, Gross CP, Gajra A, Lichtman SM, Ramani R, Katheria V, Zavala L, Hurria A.
Chicago, United States 2012
Regional variation in treatment costs and survival for elderly patients with myelodysplastic syndromes. Ma X, Wang R, Long JB, Gold HT, Halene S, Gross CP.
Chicago, United States 2012
Patterns of use and short-term complications of breast brachytherapy in the national Medicare population: 2008-2009. Presley CJ, Soulos PR, Herrin J, Roberts KB, Yu JB, Killelea BK, Lesnikoski BA, Long JB, Gross CP.
Chicago, United States 2012
. The Relationship among Age, Anxiety, and Depression in Older Adults with Cancer. Weiss T, Nelson CJ, Tew WP, Hardt M, Mohile SG, Owusu C, Klepin HD, Gross CP, Gajra A, Lichtman SM, Ramani R, Katheria V, Zavala L, Hurria A.
Chicago, United States 2012
Proton radiotherapy for prostate cancer in the Medicare population: Patterns of care and comparison of early toxicity with IMRT. Yu JB, Soulos PR, Cramer LD, Roberts KB, Herrin J, Potosky AL, Gross CP.
Chicago, United States 2012
Are bilateral mastectomy rates among older women rising due to preoperative breast MRI? Killelea BK, Long JB, Ma X, Soulos PR, Chagpar AB, Gross CP.
Phoenix, United States 2012
The effect of computer aided detection (CAD) on breast biopsy and breast cancer detection in a Medicare population. Killelea BK, Long JB, Ma X, Wang R, Chagpar AB, Gross CP.
Phoenix, United States 2012
Understanding and decision making about screening colonoscopy for older persons with multimorbidity. Lewis C, Fried T, Ross JS, Aminawung J, Werner L, Kistler C, Tinetti M, McKenzie D, Genao I, Gross CP.
Orlando, United States 2012
The effect of age-specific guidelines on screening older women for cancer. Licurse A, Soulos PR, Quon JL, Gross CP.
Orlando, United States 2012
National utilization patterns of Mohs Micrographic Surgery for malignant melanoma in situ. Viola KV, Gonsalves L, Gross CP, Turner RB.
Raleigh, United States 2012
Management of stage 1 breast cancer for women under the age 65: The influence of regional radiation oncologist and general surgeon services on treatment choice. Aneja S, Smith BD, Wilson LD, Haffty BG, Gross CP, Yu JB.
Las Vegas, United States 2012
Risk of heart failure or cardiomyopathy associated with adjuvant trastuzumab or chemotherapy in older women with breast cancer. Chen J, Long JB, Steingart RM, Gross CP.
Chicago, United States 2012
Incidence of Heart Failure or Cardiomyopathy after Adjuvant Trastuzumab Therapy for Breast Cancer: A SEER-Medicare Analysis. Chen J, Long JB, Steingart RM, Gross CP.
Chicago, United States 2012
The influence of regional radiation oncologist and urologist capacities on treatment choice for prostate cancer management. Yu JB, Aneja S, Makarov DV, Roberts KB, Gross CP.
San Francisco, United States 2012
The influence of physician densities and patient characteristics on the decision to treat prostate cancer patients with varying clinical benefit. Yu JB, Aneja S, Makarov DV, Roberts KB, Gross CP.
San Francisco, United States 2012
White Coats, Grass Roots, and Health Reform (Panel Speaker)
Atlanta, United States 2011
Understanding Cancer Screening and Outcomes in an Aging Population
London, United Kingdom 2011
Influence of physician densities and patient characteristics on the decision to treat prostate cancer patients with varying clinical benefit. Aneja S, Makarov DV, Gross CP, Roberts KB, Yu JB.
Miami, United States 2011
Influence of regional radiation oncologist and urologist capacities on treatment choice for prostate cancer. Aneja S, Gross CP, Makarov DV, Roberts KB, Yu JB.
Miami, United States 2011
Are the efforts of current clinical trials involving radiation therapy focused on the evidence gaps in cancer treatment? Lloyd S, Gross CP, Makarov DV, Yu JB.
Miami, United States 2011
Primary dose reduction of chemotherapy in patients older than age 65 with advanced cancer and toxicity outcomes. Ajeet Gajra, Hurria J, Togawa K, Mohile S, Owusu C, Kleipin H, Gross CP, Lichtman S, Bhatia S, Katheria BS, Klapper S, Hansen K, Ramani R, Lachs M Wong FL, Tew W.
Chicago, United States 2011
Do cancer survivors follow screening guidelines better? Chagpar A, Sanft T, Gross CP.
Chicago, United States 2011
Predictors of primary dose reduction (PDR) among patients age 65 and older receiving adjuvant chemotherapy. Kleipin H, Ajeet Gajra, Hurria J, Togawa K, Mohile S, Owusu C, Gross CP, Lichtman S, Bhatia S, Katheria BS, Klapper S, Hansen K, Ramani R, Lachs M Wong FL, Tew W.
Chicago, United States 2011
Racial disparities in prostate cancer treatment: Understanding the contribution of inappropriate care. Presley CJ, Raldow AC, Cramer LD, Soulos PR, Long JB, Makarov DV, Yu JB, Gross CP.
Chicago, United States 2011
Racial disparities in prostate cancer treatment: The contribution of inappropriate care. Presley C, Yu J, Soulos P, Long J, Cramer L, Gross CP.
Chicago, United States 2011
A geographic analysis of the radiation oncology workforce. (2011 Young Oncologist Essay Award – Sanjay Aneja) Aneja S, Smith BD, Gross CP, Wilson LD, Haffty BG, Roberts KB, Yu JB.
Palm Beach, United States 2011
A new paradigm in the interpretation of observational studies evaluating postoperative radiation therapy. Park HS, Gross CP, Yu JB.
Palm Beach, United States 2011
Adoption of Invasive Clinical Staging Techniques in Stage IIIA Non-Small Cell Lung Cancer Lags Adoption of Positron Emission Tomography. Vest MT, Tanoue L, Detterbeck F, Gross CP.
Denver, United States 2011
Adoption of invasive clinical staging techniques in stage IIIA non-small cell lung cancer. Vest MT, Tanoue L, Soulos PR, Kim AW, Detterbeck FC, Morgensztern D, Gross CP.
Denver, United States 2011
Head & Neck Cancer(HNC)Patients Undergoing Int Modulated Rad Therpy(IMRT) Have Fewer Subsequent DaysOfHosp(DOH) than Do Patients Undergoing Conventional Rad Therpy(CRT) in the SEER-Medicare Linked Database. Gross CP, Soulos PM, Sharma R, Makarov DV, Decker RJ, Smith BD, Desai RA, Cramer LD, Yu JB.
San Diego, United States 2011
Understanding Comorbidity and Cancer
Chicago, United States 2010
Underrepresentation of Older Persons in Clinical Trials: Implications for Comparative Effectiveness Research
Chicago, United States 2010
Head&NeckCancer(HNC) Patients Undergoing PrimaryRad w IntensityModulatedRadiationTherpy(IMRT) Demonstrate ImprovedOverallSurvival(OS) Comp to Undergo ConventionalRadiationTherapy(CRT) in SEER-Medicare Link Database. YuJB, SoulosPM, SharmaR, MakarovDV, DeckerRJ, SmithBD, DesaiRA, CramerLD, GrossCP
San Diego, United States 2010
. Effect of sex, age and life expectancy on receipt of screening colonoscopy in the Medicare population. Gancayco J, Khiani V, Soulos P, Cramer L, Ross J, Braithwaite S, Genao I, Tinetti M, Gross CP.
New Orleans, United States 2010
Radiology Alone for 5+ Brain Metatases – Expert Opinion Survey. Knisely, J, Yamamoto M, Chiang, V, Castrucci W, Gross C, Jokura H.
Athens, Greece 2010
Burden of comorbidity among Medicare beneficiaries with heart failure. Ahluwalia SC, Gross CP, Chaudhry SI, Fried TR.
Minneapolis, United States 2010
Comorbidity and mortality in advanced heart failure. Ahluwalia SC, Gross CP, Chaudhrey SI, Fried TR.
Minneapolis, United States 2010
Renal ultrasound in the evaluation of acute kidney injury: Developing a risk stratification framework. Licurse A, Formica R, Forman H, Parikh C, Dzuira J, Makarov D, Kim M, Gross CP.
Minneapolis, United States 2010
Conflict of Interest in Clinical Research: An Empirical Overview
Washington, United States 2009
Focusing on the Big Picture: Integrating Chronic Illness Burden into Decisions about Cancer Screening and Treatment
Boston, United States 2009
Care of the Cancer Survivor
New London, United States 2009
Geriatric assessment of older adults with cancer: Baseline data from a 500 patient multi-center study. Hurria A, Mohile S, Lichtman S, Owusu C, Klepin H, Gross CP, Hansen K, Klapper S, Togawa K, Tew W.
Orlando, United States 2009
The effect of the 2003 EMTALA Update on trauma care. Mitesh R, Epstein A, Martin E, Gross CP.
Chicago, United States 2009
The shortage of on-call coverage: understanding the issue. Rao M, Lerro C, Gross CP.
Chicago, United States 2009
The effect of the 2003 EMTALA Update on trauma care. Rao M, Epstein A, Martin E, Gross CP.
New Orleans, United States 2009
The shortage of on-call coverage: understanding the issue. Rao M, Lerro C, Gross CP.
New Orleans, United States 2009
Regional variation in total cost of radical prostatectomy: evidence from the 2004 Healthcare Cost and Utilization Project Nationwide Inpatient Sample. Makarov D, Loeb S, Landman AB, Nielsen ME, Gross CP, Penson DF, Desai RA.
Chicago, United States 2009
Validating the Partin tables using the NCI SEER Database. Yu J, Makarhov D, Partin J, Gross CP.
Chicago, United States 2009
Radiosurgery practitioner attitudes regarding the use of stereotactic radiosurgery alone for oligometastatic brain metastases. Knisely JPS, Castrucci WA, Gross CP, Chiang VL.
Mont-Tremblant, Canada 2009
Conflict of Interest in Medicine: Is There a Policy Solution?
New York, United States 2007
Conflict of Interest in Clinical Research: An Empirical Overview
Washington, United States 2007
Impact of Third Party Payer Policies on Clinical Trial Enrollment: What does the Evidence Say
Baltimore, United States 2007
Financial Conflict of Interest and Clinical Research: Impact on Scientific Integrity
Bethesda, United States 2007
The Practicing Oncologist-Pharmaceutical Industry Relationship: What are the Ethical Bounds?
Chicago, United States 2007
Multi-morbidity and Cancer Outcomes: An Integrated Approach
Detroit, United States 2007
Conflict of Interest in Clinical Research: Update for 2007
Bethesda, United States 2007
Primary Care of the Diabetic Patient
Bridgeport, United States 2007
Financial Conflict of Interest and Clinical Research: Impact on Scientific Integrity
Bethesda, United States 2006
Conflict of Interest in Clinical Research
Bethesda, United States 2006
Race and Clinical Trial Enrollment: What do the Data Say?
Washington, United States 2006
Cancer in Underserved Populations: Scope of the Problem in Connecticut
New Haven, United States 2006
Financial Conflict of Interest and Clinical Research: Impact on Scientific Integrity
Bethesda, United States 2005
Financial Conflict of Interest and Clinical Research: Beware the Medical Industrial Complex
Bethesda, United States 2005
Genetics in Primary Care: A Challenge for the New Millennium
New Haven, United States 2005
Financial Conflict of Interest and Clinical Research: Where Should We Go From Here?
New York, United States 2005
Financial Conflict of Interest and Medical Research: Beware the Medical Industrial Complex
New Orleans, United States 2004
Industry-Sponsored Research and the New PhRMA Guidelines – A Perspective from an Academic Medical Center
Pittsburgh, United States 2003
Financial Conflict of Interest in Scientific Publication
Pittsburgh, United States 2003
Barriers to Participation in Cancer Research: Insights from National Cancer Institute Enrollment Data
New York, United States 2003
Financial Conflict of Interest and Medical Research: Beware the Medical Industrial Complex
Washington, United States 2003
Using Disease Burden to Guide Allocation Decisions: Pros and Cons
Bethesda, United States 1999